[Federal Register Volume 67, Number 133 (Thursday, July 11, 2002)]
[Notices]
[Page 45981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-17478]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Renewals

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing the 
renewal of certain FDA advisory committees by the Deputy Commissioner 
of Food and Drugs (the Deputy Commissioner). The Deputy Commissioner 
has determined that it is in the public interest to renew the charters 
of the committees listed in the following table for an additional 2 
years beyond charter expiration date. The new charters will be in 
effect until the dates of expiration listed in the following table. 
This notice is issued under the Federal Advisory Committee Act of 
October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).

DATES:  Authority for these committees will expire on the dates 
indicated in the following table unless the Deputy Commissioner 
formally determines that renewal is in the public interest.

------------------------------------------------------------------------
         Name of committee                    Date of expiration
------------------------------------------------------------------------
Medical Imaging Drugs Advisory       February 28, 2004
 Committee
Gastrointestinal Drugs Advisory      March 3, 2004
 Committee
Advisory Committee for Reproductive  March 23, 2004
 Health Drugs
Arthritis Advisory Committee         April 5, 2004
Veterinary Medicine Advisory         April 24, 2004
 Committee
Anesthetic and Life Support Drugs    May 1, 2004
 Advisory Committee
Blood Products Advisory Committee    May 13, 2004
Pulmonary-Allergy Drugs Advisory     May 30, 2004
 Committee
Drug Safety and Risk Management      May 31, 2004
 Advisory Committee (formerly Drug
 Abuse Advisory Committee)
Science Advisory Board/NCTR          June 2, 2004
Peripheral and Central Nervous       June 4, 2004
 System Drugs Advisory Committee
Psychopharmacologic Drugs Advisory   June 4, 2004
 Committee
Transmissible Spongiform             June 9, 2004
 Encephalopathies Advisory
 Committee
------------------------------------------------------------------------


FOR FURTHER INFORMATION CONTACT: Linda A. Sherman, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

    Dated: July 5, 2002.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 02-17478 Filed 7-10-02; 8:45 am]
BILLING CODE 4160-01-S